Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration
NCT ID: NCT07024342
Last Updated: 2026-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
180 participants
INTERVENTIONAL
2022-10-04
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adherence and Perspiration While Wearing Lower Limb Prostheses
NCT03900845
Moisture Management Liner Effectiveness Study
NCT04427007
Influence of Socket Volume on Prosthesis Performance
NCT02124915
Study to Determine if Different Prosthetic Sockets Effect How Much Oxygen is in the Tissue of Lower Limb Amputees While They Are Walking
NCT00985842
Comparative Effectiveness of Socket Casting Methods: Improving Form and Fit
NCT04141748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For individuals who do have problems with residual limb perspiration, some may be able to stop their activity when it accumulates, remove their prosthesis, dry it and their residual limb, then don it again and carry on. Others, like the military service personnel, may not have such an opportunity. These individuals can be prescribed a perforated liner through which perspiration can drain, or a thin, special purpose half-ply sock worn between the skin and liner, which can reduce the lubricating effects of perspiration. Current commercially-available perforated liners come with two different sized holes: one with small holes the size of a pinprick, and one with somewhat larger holes the size of a pinhead. There is little evidence available to suggest which of the three approaches is best.
The aim of the proposed research is to compare these three clinically-available options and determine which is best at addressing the problem of perspiration accumulation inside the prosthesis. To achieve this aim, we propose to recruit 180 individuals with below-knee amputations to participate in a human subject experiment. Upon enrollment, we will administer a survey to measure the stability, suspension, and comfort of their socket. Subjects will then receive one of three study-provided liners: (1) a liner-liner, (2) a liner perforated with very small diameter holes, or (3) a liner perforated with somewhat larger diameter holes. After subjects have worn the study-provided liner for two weeks, we will administer the survey again. The results of this research will identify which of the three clinically-available options is best at addressing the problem of perspiration accumulation inside the prosthesis.
More than half a million Americans live with a lower limb amputation, and a few thousand of these were on active duty when it happened. For the many individuals with a lower limb amputation who have problems with perspiration, the results of this two-year study will be of value as it will help them, and their clinicians, choose the best commercially-available solution.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Liner perforated with very small diameter holes
Subjects will wear their prosthesis in their home, work, and community environments while they will participate in their usual activities for two weeks.
Liner perforated with very small diameter holes
A commercially available, elastomeric liner perforated with very small holes (approximately 0.3 mm diameter) to allow perspiration to drain. This liner is worn between the skin and the participant's prosthetic socket.
As-prescribed liner
A commercially available, elastomeric liner with no perforations. This liner is worn between the skin and the participant's prosthetic socket.
Liner perforated with somewhat larger diameter holes
Subjects will wear their prosthesis in their home, work, and community environments while they will participate in their usual activities for two weeks.
Liner perforated with somewhat larger diameter holes
A commercially available, elastomeric liner perforated with somewhat larger holes (approximately 1.5 mm diameter) to allow perspiration to drain. This liner is worn between the skin and the participant's prosthetic socket.
As-prescribed liner
A commercially available, elastomeric liner with no perforations. This liner is worn between the skin and the participant's prosthetic socket.
Liner-liner
Subjects will wear their prosthesis in their home, work, and community environments while they will participate in their usual activities for two weeks.
Liner-liner
A thin, special purpose half-ply sock which may reduce the effects of perspiration. The liner-liner is worn between the skin and the participant's as-prescribed liner.
As-prescribed liner
A commercially available, elastomeric liner with no perforations. This liner is worn between the skin and the participant's prosthetic socket.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Liner perforated with very small diameter holes
A commercially available, elastomeric liner perforated with very small holes (approximately 0.3 mm diameter) to allow perspiration to drain. This liner is worn between the skin and the participant's prosthetic socket.
Liner perforated with somewhat larger diameter holes
A commercially available, elastomeric liner perforated with somewhat larger holes (approximately 1.5 mm diameter) to allow perspiration to drain. This liner is worn between the skin and the participant's prosthetic socket.
Liner-liner
A thin, special purpose half-ply sock which may reduce the effects of perspiration. The liner-liner is worn between the skin and the participant's as-prescribed liner.
As-prescribed liner
A commercially available, elastomeric liner with no perforations. This liner is worn between the skin and the participant's prosthetic socket.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Been fit with a prosthesis and used it for at least six months
* Wear the prosthesis for four or more hours on average per day
* Have, or will have access to a computer, tablet, or smartphone with video conferencing ability
* Currently have problems with residual limb perspiration
* Currently wear a WillowWood Alpha Classic or Alpha Hybrid liner
Exclusion Criteria
* Residual limb is ulcerated
* Current skin irritation or injury on residual limb
* Osteoarthritis, injury, or pain that interferes with walking ability
* Currently incarcerated
* Pregnant
* Inadequate cognitive function or language proficiency to consent to participate
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Puget Sound Health Care System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Glenn K. Klute, PhD
Research Career Scientist / Affiliate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Glenn K Klute, PhD
Role: PRINCIPAL_INVESTIGATOR
US Department of Veterans Affairs
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Puget Sound Health Care System Seattle Division
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1588234
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.